Literature DB >> 19419812

Shikonin, an ingredient of Lithospermum erythrorhizon, down-regulates the expression of steroid sulfatase genes in breast cancer cells.

Yi Zhang1, Rui-Qin Qian, Ping-Ping Li.   

Abstract

Steroid sulfatase (STS) has an important role in regulating the biosynthesis of estrogen within breast tumors. We aimed to investigate whether shikonin, an ingredient of Lithospermum erythrorhizon, could modulate STS expression in breast cancer cells. By MTT assay, shikonin inhibited the cell proliferation of breast cancer cells MCF-7 and SK-BR-3. Moreover, by semi-quantitative/quantitative reverse transcription polymerase chain reaction and dual-luciferase reporter based bioluminescent measurements, the mRNA and enzymatic activity levels of STS were decreased after shikonin treatment. Concluding, shikonin could act as a selective estrogen enzyme modulator by down-regulating the STS expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19419812     DOI: 10.1016/j.canlet.2009.04.008

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  16 in total

1.  RNA interference-mediated phosphodiesterase 4D splice variants knock-down in the prefrontal cortex produces antidepressant-like and cognition-enhancing effects.

Authors:  Zhen-Zhen Wang; Yi Zhang; Yan-Qin Liu; Nan Zhao; You-Zhi Zhang; Li Yuan; Lei An; Jing Li; Xiao-Yun Wang; Juan-Juan Qin; Steven P Wilson; James M O'Donnell; Han-Ting Zhang; Yun-Feng Li
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

2.  Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer.

Authors:  Ramkishore Gernapudi; Yuan Yao; Yongshu Zhang; Benjamin Wolfson; Sanchita Roy; Nadire Duru; Gabriel Eades; Peixin Yang; Qun Zhou
Journal:  Breast Cancer Res Treat       Date:  2015-03-18       Impact factor: 4.872

Review 3.  Targeting tumor proteasome with traditional Chinese medicine.

Authors:  Huanjie Yang; Jinbao Liu; Q Ping Dou
Journal:  Curr Drug Discov Technol       Date:  2010-03

4.  PKM2 inhibitor shikonin suppresses TPA-induced mitochondrial malfunction and proliferation of skin epidermal JB6 cells.

Authors:  Wenjuan Li; Joan Liu; Yunfeng Zhao
Journal:  Mol Carcinog       Date:  2012-12-19       Impact factor: 4.784

5.  Shikonin induces mitochondria-mediated apoptosis and enhances chemotherapeutic sensitivity of gastric cancer through reactive oxygen species.

Authors:  Wenquan Liang; Aizhen Cai; Guozhu Chen; Hongqing Xi; Xiaosong Wu; Jianxin Cui; Kecheng Zhang; Xudong Zhao; Jiyun Yu; Bo Wei; Lin Chen
Journal:  Sci Rep       Date:  2016-12-01       Impact factor: 4.379

6.  Transgenic studies reveal the positive role of LeEIL-1 in regulating shikonin biosynthesis in Lithospermum erythrorhizon hairy roots.

Authors:  Rongjun Fang; Ailan Zou; Hua Zhao; Fengyao Wu; Yu Zhu; Hu Zhao; Yonghui Liao; Ren-Jie Tang; Yanjun Pang; Rongwu Yang; Xiaoming Wang; Jinliang Qi; Guihua Lu; Yonghua Yang
Journal:  BMC Plant Biol       Date:  2016-05-26       Impact factor: 4.215

7.  Shikonin reduces tamoxifen resistance through long non-coding RNA uc.57.

Authors:  Chen-Han Zhang; Jue Wang; Lin-Xin Zhang; Yi-Han Lu; Tian-Hao Ji; Lu Xu; Li-Jun Ling
Journal:  Oncotarget       Date:  2017-09-11

8.  RNA-seq transcriptome analysis of breast cancer cell lines under shikonin treatment.

Authors:  Kuo-Hua Lin; Ming-Yii Huang; Wei-Chung Cheng; Shu-Chi Wang; Shih-Hua Fang; Hung-Pin Tu; Chia-Cheng Su; Yung-Li Hung; Po-Len Liu; Chi-Shuo Chen; Yu-Ting Wang; Chia-Yang Li
Journal:  Sci Rep       Date:  2018-02-08       Impact factor: 4.379

9.  Identification of New Shikonin Derivatives as Antitumor Agents Targeting STAT3 SH2 Domain.

Authors:  Han-Yue Qiu; Xiang Zhu; Yue-Lin Luo; Hong-Yan Lin; Cheng-Yi Tang; Jin-Liang Qi; Yan-Jun Pang; Rong-Wu Yang; Gui-Hua Lu; Xiao-Ming Wang; Yong-Hua Yang
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

10.  Shikonin induces apoptosis of HaCaT cells via the mitochondrial, Erk and Akt pathways.

Authors:  Huiling Jing; Wenyan Sun; Jinghua Fan; Yanmin Zhang; Jiao Yang; Jinjing Jia; Jichang Li; Jiaqi Guo; Suju Luo; Yan Zheng
Journal:  Mol Med Rep       Date:  2016-02-19       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.